Log in

LON:CSRTConsort Medical Share Price, Forecast & News

GBX 1,010
+1,010.00 (+∞)
(As of 03/5/2020)
Today's Range
Now: GBX 1,010
50-Day Range
MA: GBX 1,010
52-Week Range
Now: GBX 1,010
Volume770 shs
Average Volume23,005 shs
Market Capitalization£504.60 million
P/E Ratio127.85
Dividend Yield2.75%
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.
Read More
Consort Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars

Industry, Sector and Symbol

Industry Medical Appliances & Equipment



Sales & Book Value

Annual Sales£298.60 million
Cash FlowGBX 30.20 per share
Book ValueGBX 465.50 per share



Market Cap£504.60 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CSRT News and Ratings via Email

Sign-up to receive the latest news and ratings for CSRT and its competitors with MarketBeat's FREE daily newsletter.

Consort Medical (LON:CSRT) Frequently Asked Questions

How has Consort Medical's stock been impacted by COVID-19 (Coronavirus)?

Consort Medical's stock was trading at GBX 1,010 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CSRT stock has increased by 0.0% and is now trading at GBX 1,010. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Consort Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Consort Medical in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Consort Medical.

What price target have analysts set for CSRT?

2 brokerages have issued twelve-month price targets for Consort Medical's shares. Their forecasts range from GBX 1,010 to GBX 1,010. On average, they expect Consort Medical's share price to reach GBX 1,010 in the next twelve months. View analysts' price targets for Consort Medical.

Has Consort Medical been receiving favorable news coverage?

Media coverage about CSRT stock has been trending somewhat negative on Saturday, according to InfoTrie. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Consort Medical earned a daily sentiment score of -1.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Consort Medical.

Who are some of Consort Medical's key competitors?

What other stocks do shareholders of Consort Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Consort Medical investors own include Chubb (CB), Newcrest Mining (NCM), Petrel Resources (PET), Barrick Gold (ABX), Ascot Mining Plc Lon (ATMGF), BK IRELAND GRP/ADR (BKRIY), Caleres (CAL), Choice Hotels International (CHH), Colony Capital (CLNY) and JD Sports Fashion (JD).

Who are Consort Medical's key executives?

Consort Medical's management team includes the following people:
  • Mr. Jonathan M. Glenn, CEO & Director (Age 50)
  • Mr. Paul Hayes, CFO & Exec. Director (Age 52)
  • Mr. Andrew Jackson, Group Gen. Counsel & Company Sec.
  • Ms. Lisa King, Director of HR
  • Colin Leeder, Group Financial Controller

What is Consort Medical's stock symbol?

Consort Medical trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."

How do I buy shares of Consort Medical?

Shares of CSRT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Consort Medical's stock price today?

One share of CSRT stock can currently be purchased for approximately GBX 1,010.

How big of a company is Consort Medical?

Consort Medical has a market capitalization of £504.60 million and generates £298.60 million in revenue each year.

What is Consort Medical's official website?

The official website for Consort Medical is www.consortmedical.com.

How can I contact Consort Medical?

Consort Medical's mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The company can be reached via phone at +44-1442-867920.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.